TRISALUS LIFE SCIENCES, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.45 USD | -3.54% |
|
-1.62% | -35.50% |
| Jun. 03 | TriSalus Life Sciences, Inc. Highlights Clinical Data from Phase 1b Perio-02 Trial | CI |
| May. 30 | Canaccord Genuity Initiates TriSalus Life Sciences at Buy Rating With $12 Price Target | MT |
00479a2995ac457242142f449a6.muXF4qiCXjqsI7IWWYQLRDcOue3R5K5L3OYBu2wrs2A.rK6LlM-6LFXDZ_VgNNxgClZDiYWhlPEsmqNEzy1N2FDskIa28PE6eMdX5w~c24c4243ea3f4a9f6a8e8409a3e2b08c
